powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1033561998
Huzaifa Jaliawala
Pulmonary Disease
Oklahoma City,
OK
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 070011
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
287
Unique beneficiaries
—
Total services
387
Distinct HCPCS
7
Medicare payment
$35K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 102 Pulmonary Disease providers in OK — bottom quintile (cohort median 918).
PRESCRIBING · PART D · 2024
Total Rx claims
636
Beneficiaries
—
Total drug cost
$278K
Distinct drugs
14
Brand share
75.5%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
164 claims
Budesonide/Glycopyr/Formoterol
69 claims
Fluticasone/Vilanterol
60 claims
Fluticasone Propionate
55 claims
Albuterol Sulfate
54 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$523
Payment records
23
By payment type
Food and Beverage
$523
Top paying entities
Food and Beverage
$523
QUALITY · MIPS · 2024
Final MIPS score
88.0
Quality
70.3
Cost
75.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
Group
